Birds In Spring: Taking In Good News With The Bad
A group of researchers in India published a study recently that had me jump to two conclusions. Their research followed 170 autologous stem cell transplant patients over the years, starting around...
View ArticleBeacon NewsFlashes – November 21, 2012
Dr. Jason Valent Joins The Beacon’s Medical Advisor Team – Dr. Jason Valent, associate staff in the Hematologic Oncology and Blood Disorders Department of the Cleveland Clinic’s Taussig Cancer...
View ArticleManhattan Tales: Thanksgiving In Sandy’s Wake
I’m writing this column a few days before Thanksgiving, on a bright and glorious fall day. There’s a little excitement in the air, as we prepare to take the train to Washington D.C. to have a...
View ArticleBeacon NewsFlashes – November 26, 2012
Researchers Observe High Rate Of Osteonecrosis Of The Jaw In Myeloma Patients After Stem Cell Transplantation – In a recent retrospective study, German researchers observed a high rate of osteonecrosis...
View ArticlePat’s Cracked Cup: The Perils And Humor Of Dating While Living With Multiple...
I imagine people with spouses and significant others have someone who helps them remember. It would be hard to erase the marks of disease from life. For those of us who are unpartnered, it’s easier to...
View ArticleSecond Transplant May Be An Effective And Safe Salvage Therapy For Certain...
Findings from a recent retrospective study indicate that a second autologous stem cell transplant may be an effective and safe salvage therapy for certain relapsed and refractory multiple myeloma...
View ArticlePersonal Perspective: Smoldering Myeloma Patient Becomes Her Own Best Advocate
After a routine blood test, Yolanda Brunson-Sarrabo was diagnosed with myeloma in 2008 at the age of 38. Like many patients before her, Yolanda was unfamiliar with the term “multiple myeloma” prior to...
View ArticleThe Myeloma Beacon To Report The Latest Research From The Upcoming American...
The American Society of Hematology (ASH) will kick off its 54th annual meeting next Saturday, December 8. This year’s meeting will run through Tuesday, December 11 and will be held in Atlanta. Similar...
View ArticleMyeloma Patients With Early Relapse After Stem Cell Transplant May Benefit...
Results of a recent small Australian study suggest that multiple myeloma patients who relapse within 12 months of their first transplant may benefit from a second transplant with melphalan plus Velcade...
View ArticleSean’s Burgundy Thread: Wednesdays With Murray
While I am not so much a creature of habit, my Wednesday afternoon activities over the last three years have been pretty much chiseled in stone. At around noon on a typical Wednesday, I drop everything...
View ArticleBeacon NewsFlashes – December 5, 2012
Itraconazole May Increase The Risk Of Early Peripheral Neuropathy In Myeloma Patients Receiving Velcade – Results of a recent Japanese study indicate that itraconazole (Sporanox), a medication used for...
View ArticlePat’s Place: The Switch
Living with multiple myeloma isn’t easy for a number of reasons. Besides having cancer and dealing with the uncertainty around it, there are hours spent in waiting rooms, along with countless blood...
View ArticleStem Cell Transplants Linked To Higher Risk Of Irregular Heart Beat In...
Results from a recent retrospective study indicate that multiple myeloma patients who receive stem cell transplants may be at greater risk than the general population of developing atrial fibrillation,...
View ArticleTips For Making Sense Of The Research Results Presented At This Year’s ASH...
Today marks the first day of presentations and poster sessions at the 2012 American Society of Hematology (ASH) annual meeting. The meeting, which is being held in Atlanta this year, will provide the...
View ArticleASH 2012 Multiple Myeloma Update – Day One: Poster Sessions
Yesterday was the first day of research presentations at this year’s American Society of Hematology (ASH) annual meeting, which is being held in Atlanta. Research findings related to multiple myeloma...
View ArticleASH 2012 Multiple Myeloma Update – Day Two: Early Afternoon Oral Session
This year’s American Society of Hematology (ASH) annual meeting, which is being held in Atlanta, began yesterday and goes through Tuesday. Today’s myeloma-related presentations began this afternoon...
View ArticleASH 2012 Multiple Myeloma Update – Day Two: Late Afternoon Oral Session
Yesterday was the second day of the 2012 American Society of Hematology (ASH) annual meeting, which is being held in Atlanta. The day’s myeloma-related presentations began in the afternoon with three...
View ArticleASH 2012 Multiple Myeloma Update – Day Two: Poster Sessions
Yesterday was the second day of the 2012 American Society of Hematology (ASH) annual meeting. Although the myeloma-related sessions got a bit of a late start, the day featured a wide range of...
View ArticleASH 2012 Multiple Myeloma Update – Day Three: Early Morning Oral Session
Today is the third day of the American Society of Hematology (ASH) 2012 annual meeting in Atlanta, and it is packed full with multiple myeloma-related presentations. Presentations started early in the...
View ArticleASH 2012 Multiple Myeloma Update – Day Three: Late Morning Oral Session
This year’s American Society of Hematology (ASH) meeting continues in Atlanta. Yesterday was the third day of the meeting and the busiest day in terms of myeloma-related presentations. It was packed...
View Article
